Cargando…
An update review of emerging small-molecule therapeutic options for COVID-19
The SARS-CoV-2 outbreak and pandemic that began near the end of 2019 has posed a challenge to global health. At present, many candidate small-molecule therapeutics have been developed that can inhibit both the infection and replication of SARS-CoV-2 and even potentially relieve cytokine storms and o...
Autores principales: | Tian, Dengke, Liu, Yuzhi, Liang, Chengyuan, Xin, Liang, Xie, Xiaolin, Zhang, Dezhu, Wan, Minge, Li, Han, Fu, Xueqi, Liu, Hong, Cao, Wenqiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Author(s). Published by Elsevier Masson SAS.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7857046/ https://www.ncbi.nlm.nih.gov/pubmed/33556871 http://dx.doi.org/10.1016/j.biopha.2021.111313 |
Ejemplares similares
-
The development of Coronavirus 3C-Like protease (3CL(pro)) inhibitors from 2010 to 2020
por: Liu, Yuzhi, et al.
Publicado: (2020) -
A promising antiviral candidate drug for the COVID-19 pandemic: A mini-review of remdesivir
por: Liang, Chengyuan, et al.
Publicado: (2020) -
An Update on Emerging Therapeutic Options for Malignant Pleural Mesothelioma
por: Davis, Alexander, et al.
Publicado: (2022) -
RNA-dependent RNA polymerase (RdRp) inhibitors: The current landscape and repurposing for the COVID-19 pandemic
por: Tian, Lei, et al.
Publicado: (2021) -
Clinical Management of Anemia in Patients with Myelodysplastic Syndromes: An Update on Emerging Therapeutic Options
por: Lewis, Russell, et al.
Publicado: (2021)